Vasamed Stock Analysis

VSMD Stock  USD 0.0001  0.00  0.00%   
Vasamed is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Vasamed pink sheet analysis is to determine its intrinsic value, which is an estimate of what Vasamed is worth, separate from its market price. There are two main types of Vasamed's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Vasamed's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Vasamed's stock to identify patterns and trends that may indicate its future price movements.
The Vasamed pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Vasamed is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Vasamed Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Vasamed's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vasamed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Vasamed Pink Sheet Analysis Notes

The company recorded a loss per share of 0.24. Vasamed had not issued any dividends in recent years. The entity had 1:6 split on the 16th of September 2002. Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.The quote for Vasamed is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Michael Schreiber at 952-944-5857 or visit https://www.vasamed.com.

Vasamed Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Vasamed's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Vasamed or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Vasamed generated a negative expected return over the last 90 days
Vasamed has some characteristics of a very speculative penny stock
Vasamed has a very high chance of going through financial distress in the upcoming years
The company currently holds 1.8 M in liabilities. Vasamed has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vasamed until it has trouble settling it off, either with new capital or with free cash flow. So, Vasamed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vasamed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vasamed to invest in growth at high rates of return. When we think about Vasamed's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 3.13 M. Net Loss for the year was (2.92 M) with profit before overhead, payroll, taxes, and interest of 1.73 M.
Vasamed currently holds about 136.82 K in cash with (2.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Vasamed Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 28.91 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vasamed's market, we take the total number of its shares issued and multiply it by Vasamed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Vasamed Profitablity

Vasamed's profitability indicators refer to fundamental financial ratios that showcase Vasamed's ability to generate income relative to its revenue or operating costs. If, let's say, Vasamed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Vasamed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Vasamed's profitability requires more research than a typical breakdown of Vasamed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.47.

Technical Drivers

In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vasamed, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have collected data for zero technical drivers for Vasamed, which can be compared to its competition.

Vasamed Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vasamed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vasamed. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

About Vasamed Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Vasamed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vasamed shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Vasamed. By using and applying Vasamed Pink Sheet analysis, traders can create a robust methodology for identifying Vasamed entry and exit points for their positions.
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Vasamed to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Investing Opportunities Now

   

Investing Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vasamed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Vasamed Pink Sheet analysis

When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Please note, there is a significant difference between Vasamed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vasamed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vasamed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.